University of Florida grants Phageolytix an exclusive worldwide license for phage cocktail technology

The University of Florida has granted Phageolytix an exclusive worldwide license to multi-indication bacteriophage cocktails developed by researchers in its College of Medicine-Jacksonville (announced July 14, 2025). Phageolytix will manufacture GMP-grade phage cocktails and conduct the pre-clinical and clinical studies needed for FDA and other regulatory approval.